Event Summary
The ESMA, through its MiFID II regulations, proposes to regulate the use of dealing commissions by investment managers to pay for research. According to these regulations, investment managers would be expected to either use a ring-fenced research budget or absorb the cost of research on their own P&Ls. Under the new regime, investment managers will need to prioritize and optimize their external research spending to focus on areas that truly add value to their investment research process.
Neil Scarth, who has worked for over 25 years with leading buy-side and sell side firms, presentedan informed view on these regulations and their impact on the research ecosystem. He also shared his views on how investment managers can better prepare themselves operationally to manage the impact of these regulations.


Therapeutic cancer Vaccines the way forward

Your file will start downloading automatically
If it does not download within 1 minute,